Glucose Mini-Plasco B. Braun

Glucose Mini-Plasco B. Braun is an intravenous solution for injection that contains glucose monohydrate as the active ingredient. The product’s strength is not disclosed in the public specification, and it is supplied as a sterile aqueous solution intended for parenteral use. Manufactured in the European Union, it belongs to the carbohydrate (parenteral) drug class and is used in clinical settings for energy provision and fluid management.

Glucose Mini-Plasco B. Braun is indicated for several clinical situations where rapid provision of carbohydrate calories and fluid balance are required.

- Treatment of hypoglycemia when oral glucose is not feasible. - Component of parenteral nutrition regimens for patients unable to receive enteral feeding. - Fluid and electrolyte replacement in perioperative or critical‑care settings. - Support of energy metabolism during prolonged fasting or surgical procedures. - Dilution medium for compatible intravenous medications, when appropriate.

When administered intravenously, Glucose Mini-Plasco B. Braun may be associated with a range of observed effects, most of which are related to its glucose content and osmolarity.

Common: - Transient rise in blood glucose levels. - Mild hyperosmolarity leading to temporary thirst or mild nausea. - Local irritation at the infusion site, such as erythema or discomfort. - Electrolyte shifts, most commonly mild potassium changes.

Serious: - Severe hyperglycemia, especially in patients with diabetes mellitus. - Fluid overload resulting in pulmonary edema or congestive heart failure. - Hyperosmolar hyperglycemic state (HHS) in susceptible individuals.

Clinicians should observe several precautions before and during the use of Glucose Mini-Plasco B. Braun to minimize risks and ensure appropriate therapy.

- Verify patient’s blood glucose and adjust infusion rate in diabetics or those prone to hyperglycemia. - Assess fluid status and cardiac function to avoid volume overload. - Use aseptic technique to prevent catheter‑related infections. - Monitor serum electrolytes, particularly potassium and sodium, during prolonged administration. - Avoid rapid infusion in neonates or patients with compromised vascular integrity. - Consider compatibility with other IV drugs; incompatibility may cause precipitation.

Glucose Mini-Plasco B. Braun can interact with other medications or clinical conditions; awareness of these interactions helps maintain safety.

Avoid: - Avoid concurrent administration with high‑dose insulin infusions without close glucose monitoring. - Avoid mixing with calcium‑containing solutions that may precipitate. - Avoid use in patients with uncontrolled diabetes mellitus when alternative carbohydrate sources are available.

Use with caution: - Use with caution when combined with diuretics, as fluid shifts may be amplified. - Use with caution in renal impairment; monitor electrolyte balance closely. - Use with caution alongside beta‑blockers, which can mask hypoglycemia symptoms.